The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 10 3764-3769
Copyright © 1999 by The Endocrine Society
ß-Adrenergically Stimulated Fat Oxidation Is Diminished in Middle-Aged Compared to Young Subjects1
E. E. Blaak,
M. A. van Baak and
W. H. M. Saris
Department of Human Biology, Nutrition Research Center,
University of Maastricht, 6200 MD Maastricht, The Netherlands
Address all correspondence and requests for reprints to: Dr. E. E. Blaak, Department of Human Biology, Nutrition Research Center, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. E-mail: e.blaak{at}hb.unimaas.nl
 |
Abstract
|
|---|
The effect of aging on ß-adrenergically mediated substrate
utilization was investigated in nine young (25.2 ± 1.7 yr old)
and eight older males (52.9 ± 2.1 yr old), matched for body
weight and body composition. In a first experiment, the nonselective
ß-agonist isoprenaline (ISO) was infused in increasing standardized
doses, and during each infusion period energy expenditure and substrate
utilization were determined by indirect calorimetry. In a second
experiment, forearm skeletal muscle metabolism was studied during a
standardized infusion dose of ISO (19 ng/kg fat-free mass·min).
During ß-adrenergic stimulation there was an increased carbohydrate
oxidation (at an ISO infusion dose of 24 ng/kg fat-free mass·min,
31% vs. 21% of total energy expenditure;
P < 0.05) and a decreased fat oxidation (51
vs. 62 of total energy expenditure;
P < 0.05) in older compared to young subjects.
Skeletal muscle lactate release significantly increased in the older
subjects (from -175 ± 32 to -366 ± 66 nmol/100 mL forearm
tissue·min), whereas there was no change in young subjects (from
-32 ± 21 to 23 ± 57 nmol/100 mL forearm tissue·min;
interaction group x ISO, P < 0.01).
Additionally, there was a tendency toward a blunted ISO-induced
increase in nonesterified fatty acid uptake in the older
subjects (interaction group x ISO, P =
0.062). Thus, middle-aged subjects have a blunted ability to oxidize
fat during ß-adrenergic stimulation compared to young subjects. This
diminished fat oxidation may be an important etiological factor in the
age-related increase in body fatness and obesity by favoring fat
storage above oxidation.
 |
Introduction
|
|---|
AGING IS associated with increased
prevalence of chronic diseases such as cardiovascular disease and type
2 diabetes. A central phenomenon in the age-associated increased
prevalence of chronic diseases is the change in body composition,
including increased body fat mass, in particular abdominal fat (1).
Factors involved in the age-related increase in obesity may be a
decrease in physical activity (1) and a decline in energy expenditure
(2, 3, 4).
The decline in energy expenditure as a result of aging has been
hypothesized to be related to a decreased activity of the sympathetic
nervous system (5). Indeed, numerous studies reported that aging is
associated with blunted sympathetically mediated metabolic responses
(6, 7, 8, 9).
To date, little is known about the effect of aging on substrate
utilization. It has recently been shown that fat oxidation is decreased
whereas carbohydrate oxidation is increased during moderate intensity
exercise in elderly men and women (10). Previous studies in young lean
males showed that ß-adrenergic stimulation resulted in increased
skeletal muscle fatty acid uptake and utilization, whereas in obese
subjects skeletal muscle nonesterified fatty acid (NEFA) uptake was
diminished (11, 12). If aging is associated with similar changes in
sympathetically mediated fat utilization, this may result in a positive
fat balance contributing thereby to the age-related increase in
adiposity. The present study investigated, firstly, whole body
carbohydrate and fat oxidation during iv stepwise infusion of the
nonselective ß-agonist isoprenaline (ISO) and, secondly, skeletal
muscle substrate exchange during a standardized dose of ISO in healthy
young and older males matched for body weight and body composition.
 |
Subjects and Methods
|
|---|
A selected group of nine young and eight older subjects
participated in this study. Subject characteristics are indicated in
Table 1
. The older group was, on the
average, 25 yr older than the young group, and both groups had
comparable weight and body composition. Data on whole body
thermogenesis in the older subjects (6) and data on muscle metabolism
in the young subjects (11) have been previously published. All subjects
were normotensive and were generally in good health. Cardiovascular
and/or respiratory diseases were excluded by a medical questionnaire
and physical examination. All subjects engaged in sports activities no
more than 3 h a week, and none had a physically demanding job. The
study protocol was approved by the medical ethical review committee of
Maastricht University, and all subjects gave written informed consent.
The experiments were performed after an overnight fast, and room
temperature was kept between 2023 C. The study protocol consisted of
two experiments. In the first experiment, ISO was iv infused in
increasing standardized doses, and during each infusion period whole
body energy expenditure, carbohydrate and fat oxidation, and plasma ISO
concentrations were determined (ISO infusion test). In the second
experiment, forearm skeletal muscle metabolism was studied during rest
and during an iv standardized infusion of ISO (forearm muscle
experiment).
 |
ISO infusion experiment
|
|---|
In this experiment, ISO was infused in increasing doses of 6,
12, and 24 ng/kg fat-free mass (FFM)·min. The dose is related to ISO
sulfate; 69% corresponds to ISO free base. Body density was determined
by hydrostatic weighing with simultaneous lung volume measurement
(Volugraph 2000, Mijnhardt, Breda, The Netherlands). Body
composition was calculated according to the equation proposed by Siri
(13). Whole body carbon dioxide and oxygen exchange was measured by an
open circuit ventilated hood system (Oxygen Beta, Mijnhardt). The
abbreviated equation of Weir was used for calculating energy
expenditure (14), and the equations described by Frayn (15) were used
for calculating carbohydrate and fat oxidation. At the end of each
infusion period, a venous blood sample was taken with a heparinized
syringe and was put into a glutathione-containing tube on ice. The
sample was immediately centrifuged at 3000 rpm at 4 C, and the plasma
was stored at -80 C. In the plasma samples, concentrations of ISO were
determined by high performance liquid chromatography (16). During the
experiments heart rate was registered continuously. When heart rate had
risen 30 beats/min, the infusion was stopped.
 |
Forearm muscle experiment
|
|---|
Design. Forearm skeletal muscle metabolism was investigated
under baseline conditions and during iv infusion of the nonselective
ß-agonist ISO (in a dose of 19 ng/kg FFM·min). Before the start of
the experiment, three cannulas were inserted. For the sampling of
arterialized (young subjects) or arterial blood (older subjects), a
cannula was inserted in a superficial dorsal hand vein or under local
anesthesia in the radial artery of the forearm, respectively. In the
same arm, a second cannula was inserted in a forearm vein for the
infusion of ISO and the stable isotope tracer. In the contralateral
arm, a third catheter was inserted in retrograde direction in an
antecubital vein for the sampling of deep venous blood, draining
forearm muscle. To obtain arterialized blood, the hand was heated for
30 min before the first baseline sample was taken. After 30 min of rest
and after 30 min of ISO infusion, blood flow through different forearm
compartments (see below) and arterio-venous concentration differences
across forearm muscle of various metabolites were determined.
Blood flow. Total forearm blood flow (TBF) was measured by
venous occlusion plethysmography with a mercury strain gauge (Periflow
0699, Janssen Pharmaceuticals, Beerse, Belgium)
(11, 17).
To obtain an indication of whether TBF was representative of forearm
skeletal muscle blood flow, forearm skin blood flow, forearm sc adipose
tissue blood flow, and forearm composition were also determined, as
described previously (17). Subcutaneous adipose tissue blood flow
(ATBF) was measured after a sc deposition of xenon 133 (5.5
megabecquerels; 150 µCi) on the dorsal side of the forearm about 10
cm proximal to the wrist joint (for details, see Ref. 17). Skin blood
flow (SBF) was determined by the laser Doppler technique (Periflux PF3,
Perimed, Stockholm, Sweden) placed on the ventral side of the
forearm near the wrist joint. The amounts of forearm sc adipose tissue
and bone and muscle of the forearm were determined by a cross-sectional
analysis at the site of the greatest circumference of the forearm with
magnetic resonance imaging (Gyroscan T5, Philips Medical Systems,
Eindhoven, The Netherlands) (17).
Biochemical methods. Plasma NEFA, glucose, glycerol, and
lactate were measured using standard enzymatic techniques automated on
the Cobas Fara centrifugal analyzer at 340 nm (for FFA: FFA-C test kit,
Wako Chemicals, Neuss, Germany; for glucose: Unikit III, Hoffman-La
Roche, Basel, Switzerland; for glycerol and lactate: Boehringer
Mannheim, Mannheim, Germany). Plasma insulin was measured using a
specific double antibody RIA for human insulin (Kabi Pharmacia,
Uppsala, Sweden). Also, the hematocrit was determined in heparinized
blood using a microcapillary system.
 |
Calculations and statistics
|
|---|
The exchange of metabolites across forearm muscle (nanomoles per
100 mL forearm tissue/min) was calculated by multiplying the
arteriovenous difference of metabolites (micromoles per L) by total
forearm plasma blood flow [=total blood flow x (1 -
hematocrit/100); units: milliliters per 100 mL forearm tissue/min].
Skeletal muscle blood flow (SMBF) was calculated according to the
following equation (17): TBF = amount of muscle x SMBF +
amount of skin x SBF + amount of fat x ATBF, where amount
of tissue = % of total forearm area/100, blood flow is expressed
as milliliters per 100 mL tissue/min, SBF is the forearm skin blood
flow, and ATBF is forearm sc adipose tissue blood flow.
The number of subjects in the present study was based on previous
studies in our laboratory in which eight subjects per group were
sufficient to show significant differences in muscle substrate
metabolism (NEFA flux) in lean and obese subjects (11) and as result of
weight reduction (12).
Data are represented as the mean ± SE. To compare
baseline and ISO-induced responses between groups, a two-factor
repeated measures ANOVA was performed.
 |
Results
|
|---|
ISO infusion test
Both young and older subjects showed dose-related increases in
plasma ISO (P < 0.001). The increase tended to be more
pronounced in older subjects (basally and at 6, 12, and 24 ng, 0,
72 ± 55, 118 ± 19, and 212 ± 11 pg/mL) compared to
the young (basally and at 6, 12, and 24 ng, 0, 62 ± 5, 102
± 8, and 189 ± 10 pg/mL), but differences did not reach
statistical significance. Plasma norepineprine and epinephrine
concentrations were significantly higher in the older subjects compared
to the young subjects (both P < 0.001; norepinephrine
basally and 6, 12, and 24 ng: young, 176 ± 16, 217 ± 28,
226 ± 29, and 265 ± 28 pg/mL; older, 318 ± 34,
358 ± 35, 415 ± 43, and 440 ± 116 pg/mL; epinephrine
basally and 6, 12, and 24 ng: young, 24 ± 5, 15 ± 4,
16 ± 5, and 16 ± 4 pg/mL; older, 71 ± 16, 57 ±
14, 59 ± 13, and 56 ± 12 pg/mL). Figure 1
shows whole body energy expenditure and
carbohydrate and fat oxidation during infusion of increasing doses of
ISO. Resting energy expenditure was not significantly different between
the groups. Energy expenditure significantly increased during ISO
infusion in both groups (P < 0.001). There were no
significant differences in the ISO-stimulated energy expenditure
between the groups, although values were slightly lower in the older
group. Basal carbohydrate oxidation was comparable in both groups.
Carbohydrate oxidation tended to decrease during ISO in the young,
whereas there was no change in the older group (Interaction group x
ISO; P = 0.084). Basal fat oxidation was similar in
both groups. The ISO-induced increase in fat oxidation
(P < 0.001) was blunted in the older group compared to
that in the young subjects (P < 0.05). Figure 2
shows the percent contribution of
carbohydrate and fat oxidation to total energy expenditure during
baseline conditions and during ISO infusion at dose of 24 ng/kg
FFM·min. Under baseline conditions the contributions of fat and
carbohydrate oxidation to total energy expenditure are comparable in
both groups. During ISO stimulation the percent contribution of
carbohydrate oxidation to total energy expenditure is increased in the
older subjects compared to that in the young (P <
0.05), whereas there is a blunted increase in the percent contribution
of fat (P < 0.05).

View larger version (16K):
[in this window]
[in a new window]
|
Figure 1. Energy expenditure (EE) and carbohydrate and
fat oxidation during stepwise infusion of increasing doses of the
nonselective ß-agonist ISO in young and older subjects. By repeated
measures ANOVA, ISO effect: **, P < 0.001; ISO,
P = 0.001; interaction group x ISO,
P < 0.05.
|
|

View larger version (51K):
[in this window]
[in a new window]
|
Figure 2. Carbohydrate and fat oxidation, expressed as
a percentage of total energy expenditure, during the highest dose (24
ng/kg FFM·min) of a stepwise infusion of increasing doses of the
nonselective ß-agonist isoprenaline (ISO) in young and older
subjects. By repeated measures ANOVA: carbohydrate oxidation, ISO
effect, *P < 0.05, **P <
0.001; interaction group x ISO, P < 0.05.
|
|
Forearm muscle experiment
Heart rate responses. Basal heart rate values were not
different between groups (young, 57.0 ± 2; older, 57.1 ±
3.2 beats/min), whereas the increase in heart rate during ISO infusion
tended to be less pronounced in older subjects (young, 75.8 ± 3;
older, 71.1 ± 4 beats/min; interaction group x ISO,
P = 0.074).
Intermediary metabolites. Changes in arterial concentrations
of metabolites are indicated in Table 2
.
Insulin concentrations were not significantly different between groups
in both conditions. ISO infusion resulted in a significant increase in
insulin concentrations. Glucose concentrations were not different
between groups in the control group as well as during ISO infusion.
Lactate concentrations were similar in both groups, whereas there was a
significant increase in plasma lactate during ISO infusion. Basal NEFA
concentrations as well as the ISO-induced increase in NEFA
concentrations were similar in both groups. Basal glycerol
concentrations, the ISO-induced increase in glycerol concentrations,
and glycerol concentrations during ISO infusion were significantly
lower in older compared to young subjects.
View this table:
[in this window]
[in a new window]
|
Table 2. Arterial(ized) circulating concentrations of
metabolites in young and older subjects during rest and during iv
infusion of the nonselective ß-agonist isoprenaline (ISO)
|
|
Forearm muscle blood flow and forearm composition. As
indicated in Table 3
, the ISO-induced
increase in total forearm blood flow tended to be blunted in older
compared to young subjects. Forearm sc adipose tissue blood was not
different between groups under both conditions. Relative values for
skin blood flow were comparable in both, and values for skin blood flow
did not change as a result of ISO infusion. Total forearm area was
comparable in both groups (young vs. older, 5576 ± 144
vs. 5839 ± 133 mm2), and the
percentage of sc adipose tissue (13.9 ± 1.0% vs.
13.0 ± 1.0%), muscle (62.4 ± 1.1% vs.
64.5 ± 1.0%), and skin (9.3 ± 0.13% vs.
9.1 ± 0.1%) were similar in both groups. As for TBF, the changes
in SMBF tended to be blunted in the elderly (P = 0.09).
Changes in TBF reflected mainly changes in SMBF. For this reason, TBF
was used for calculating skeletal muscle substrate exchange.
View this table:
[in this window]
[in a new window]
|
Table 3. Blood flow through the different compartments of the
forearm, forearm composition, and estimated forearm skeletal muscle
blood flow during rest and during iv infusion of the nonselective
ß-agonist isoprenaline (ISO)
|
|
Forearm muscle substrate fluxes. Figure 3
shows skeletal muscle substrate fluxes
with ISO. In the basal state, forearm muscle glucose uptake tended to
be higher in older subjects compared to young, whereas lactate release
was significantly increased in the older subjects (P <
0.01). During ISO infusion, there were no changes in glucose uptake in
either group, whereas lactate release did not change in young subjects
and increased in older subjects (P < 0.01). Muscle
NEFA uptake increased during ISO infusion (P < 0.05).
The ISO-induced increase in NEFA uptake tended to be blunted in the
older subjects (P = 0.062). There were no differences
in glycerol flux between the groups.

View larger version (64K):
[in this window]
[in a new window]
|
Figure 3. Forearm skeletal muscle glucose, lactate,
NEFA, and glycerol flux (in nanomoles per 100 mL forearm tissue) during
infusion of a standardized dose of the nonselective ß-agonist ISO (19
ng/kg FFM·min). By repeated measures ANOVA: lactate, group effect:
#P < 0.001; interaction group x ISO,
¶¶P < 0.001; NEFA, ISO effect,
*P < 0.05; interaction group x ISO,
P = 0.062.
|
|
 |
Discussion
|
|---|
The present study intended to investigate whole body and skeletal
muscle substrate utilization during ß-adrenergic stimulation in young
and older subjects with comparable body weight and percent body fat.
The present study shows that there is increased carbohydrate oxidation
and decreased fat oxidation during iv infusion of the nonselective
ß-agonist ISO in the older subjects. Furthermore, the pronouncedly
increased muscle lactate release during ISO infusion in the older
subjects indicates an increased glycolytic activity. In combination
with the diminished ISO-induced increase in NEFA uptake suggests that
skeletal muscle plays an important part in this shift in substrate
utilization.
Methodological considerations
An estimation of skeletal muscle blood flow was made by
determining total sc adipose tissue and skin blood flow and by
measuring forearm composition (17). The results of the present study
show that changes in TBF are similar to changes in skeletal muscle
blood flow in both groups, indicating that it is valid to use total
forearm blood flow (or forearm plasma flow) for calculating forearm
skeletal muscle substrate fluxes. Secondly, the young subjects were
studied by using arterialized blood, whereas in the older subjects
direct arterial sampling took place. The warm air box method has been
adequately validated for the determination of most metabolites (18),
but has been criticized when applied by means of warming blankets
because it may affect blood flow to the contralateral arm (19).
However, in a previous study we showed that hand heating by a warm air
box had no or a very slight effect on body and skin temperature, deep
venous oxygen saturation, TBF, and glucose-induced oxygen consumption
of the contralateral forearm (20). On the basis of these findings, we
can exclude that the use of the warm air box method in young subjects
has interfered with the differences in muscle metabolism in older and
young subjects.
Fat oxidation
A blunted fat oxidation has been reported before during exercise
in elderly subjects (10). The present study shows for the first time
that this may be related to a decrease in ß-adrenergically mediated
fat oxidation. A factor contributing to the diminished ISO-induced fat
oxidation may simply be an impaired ß-adrenergically mediated
lipolytic response in the older subjects (9), resulting in diminished
NEFA release from adipose tissue. However, ISO-mediated arterial(ized)
NEFA concentrations as well as NEFA supply to skeletal muscle [blood
flow x arterial(ized) NEFA concentrations] were not
significantly different between both groups, suggesting that
differences in NEFA supply to skeletal muscle may not have played a
role in the present study. This is consistent with studies showing that
lipolytic rates and NEFA availability were not rate limiting for
blunted exercise-induced fat oxidation in elderly subjects (10).
Secondly, the shift in substrate utilization during ß-adrenergic
stimulation may have been caused by an age-related decline in the
capacity of skeletal muscle to oxidize fatty acids (21). Thirdly, the
higher ISO-induced increase in skeletal muscle lactate release in the
older subjects suggests increased glycolysis that may be accompanied by
increased glucose oxidation and glycogen breakdown, as reported with
epinephrine infusion (22). This increased glycolytic flux may limit the
rate of fat oxidation by inhibiting carnitine acyltransferase, the
rate-limiting enzyme for long chain fatty acid transport into the
mitochondria (23). Finally, it has been shown that the membrane
transport of long chain fatty acids may be under ß-adrenergic control
(24), which implies that differences in the activation of this
transport between young and older subjects may contribute to the
lowered fat oxidation in the older subjects. However, at present
evidence is lacking to support this speculation.
Although subjects in the present study were selected to participate no
more than 3 h a week in sports activities, we cannot exclude the
possibility that at least part of the observed differences are due to
an age-related decline in physical fitness and are not related to the
aging process per se. Indeed, training has been shown to
increase mitochondrial oxidative capacity and fat oxidation in elderly
subjects (25). However, from the latter results it cannot be determined
whether training compensates for or corrects a diminished oxidative
capacity. Additionally, although the subjects were matched for percent
body fat, we cannot exclude the possibility that differences in fat
oxidation can at least partly be explained by differences in body fat
distribution, as aging is associated with increased abdominal fat mass
(1). Thus, age-related changes in physical fitness and body fat
distribution have to be taken into account when interpreting the
disturbances in fat oxidation in the middle-aged subjects.
Lipolysis
Rates of lipolysis at rest in aging men have been reported to be
either similar to or slightly higher than rates in younger males (10, 26). This seems to contrast with data from the present study showing
lower resting arterial(ized) glycerol concentrations in the older
subjects. This apparent discrepancy may be explained by the fact that
in most previous studies the amount of body fat in the older subjects
was higher than that in younger subjects, and that lipolysis per unit
body fat may have actually been lower (26).
Thermogenesis
In a previous study we showed a blunted ISO-induced thermogenesis
in the older subjects (6). The present study shows that when the young
and older subjects are matched for percent body fat, the ISO-induced
thermogenesis is not significantly different between the groups. These
findings suggest that the previously found blunted thermogenesis may be
explained in large part by differences in percent body fat between the
young and elderly groups.
Conclusion
In summary, older (middle-aged) subjects have decreased fat
oxidation and increased carbohydrate oxidation during ß-adrenergic
stimulation compared to young subjects. This shift in substrate
utilization is reflected in increased skeletal muscle lactate release
and a tendency toward a diminished increase in NEFA uptake during
ß-adrenergic stimulation. This diminished ß-adrenergically mediated
fat utilization may be an important contributing factor to the increase
in adiposity with advancing age.
 |
Footnotes
|
|---|
1 This work was supported by a grant from the Dutch Diabetes Research
Foundation. 
Received November 24, 1998.
Revised May 17, 1999.
Revised June 16, 1999.
Accepted June 30, 1999.
 |
References
|
|---|
-
Schwartz RS. 1998 Obesity in the elderly. In:
Bray GA, Bouchard C, James WPT, eds. Handbook of obesity. New York:
Marcel Dekker; 103114.
-
Vaughan L, Zurlo F, Ravussin E. 1991 Aging and
energy expenditure. Am J Clin Nutr. 53:821825.[Abstract/Free Full Text]
-
Roberts SB, Fuss P, Heymann MB, Young VR. 1991 Influence of age on energy requirements Am J Clin Nutr. 53:821825.
-
Fukagawa NK, Bandini LG, Young JB. 1990 Effect of
age on body composition and resting metabolic rate. Am J Physiol.
259:E233E238.
-
Schwartz RS, Jaeger LF, Veith RC. 1990 The thermic
effect of feeding in older men: importance of the sympathetic nervous
system. Metabolism. 39:733737.[CrossRef][Medline]
-
Kerckhoffs DAJM, Blaak EE, van Baak MA, Saris WHM. 1998 Effect of aging on ß-adrenergically mediated thermogenesis in
men. Am J Physiol 274:E1075E1079.
-
Ford GA, Dachman WD, Blaschke TF, Hoffman BB. 1995 Effect of aging on ß2-adrenergic receptor stimulated flux of
K+, PO4, FFA, and glycerol
in human forearms. J Appl Physiol. 78:172178.[Abstract/Free Full Text]
-
Heinsimer JA, Lefkowitz RF. 1985 The impact of
aging on adrenergic receptor function: clinical and biochemical
aspects. J Am Geriatr Soc. 33:184188.[Medline]
-
Lönnqvist F, Nyberg B, Wahrenberg H, Arner
P. 1990 Catecholamine-induced lipolysis in adipose tissue of the
elderly. J Clin Invest. 85:16141621.
-
Sial S, Coggan AR, Carrol R, Goodwin J, Klein S. 1996 Fat and carbohydrate metabolism during exercise in elderly and
young subjects. Am J Physiol 271:E983E989.
-
Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MTW,
Heidendal GAK, Saris WHM. 1994 ß-Adrenergic stimulation of whole
body energy expenditure and skeletal muscle metabolism in lean and
obese men. Am J Physiol. 267:E306E315.
-
Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MTW,
Heidendal GAK, Saris WHM. 1994 ß-Adrenergic stimulation of whole
body energy expenditure and skeletal muscle metabolism in relation to
weight reduction in obese men. Am J Physiol. 267:E316E322.
-
Siri WE. 1956 The gross composition of the body. Adv Biol Med Physiol. 4:239280.
-
Weir JB. 1949 New methods for calculating metabolic
rate with special reference to protein metabolism. J Physiol. 109:19.
-
Frayn KN. 1983 Calculation of substrate oxidation
rates in vivo from gaseous exchange. J Appl Physiol. 55:628634.[Abstract/Free Full Text]
-
Smedes F, Kraak JC, Poppe H. 1982 Simple and fast
solvent extraction system for selective and quantitative isolation of
adrenaline, noradrenaline, and dopamine from plasma and urine. J
Chromatogr. 231:2539.[Medline]
-
Blaak EE, van Baak MA, Kemerink GJ, Pakbiers MTW,
Heidendal GAK, Saris WHM. 1994 Total forearm blood flow as
indicator of skeletal muscle blood flow: effect of subcutaneous adipose
tissue blood flow. Clin Sci. 87:559566.[Medline]
-
Elia M, Folmer P, Sclatman A, Goren A, Austen S. 1988 Carbohydrate, fat and protein metabolism in muscle and in the
whole body after mixed meal ingestion. Metab Clin Exp. 37:542551.
-
Astrup A, Simonsen L, Bülow J, Christensen
NJ. 1988 Measurement of forearm oxygen consumption; role of
heating of the contralateral hand. Am J Physiol.
255:E572E578.
-
Blaak EE, van Baak MA, Kempen KPG, Saris WHM. 1992 The effect of hand heating by a warm air box on oxygen consumption of
the contralateral arm. J Appl Physiol. 72:23642368.[Abstract/Free Full Text]
-
Coggan AR, Spina RJ, King DS, Rogers MA, Brown M, Nemeth
PM, Holloszy JO. 1992 Histochemical and enzymatic characteristics
of gastronemicus muscle of young and elderly men and women. J Gerontol.
47:B71B76.
-
Raz I, Katz A, Spencer MK. 1991 Epinephrine
inhibits insulin mediated glycogenesis but enhances glycolysis in human
skeletal muscle. Am J Physiol. 260:E430E435.
-
Sidossis LS, Wolfe RR. 1996 Glucose and
insulin-induced inhibition of fatty acid oxidation: the glucose-fatty
acid cycle reversed. Am J Physiol. 270:E733E738.
-
Abumrad NA, Park CR, Whitesell RR. 1986 Catecholamine activation of membrane transport of long chain fatty
acids is mediated by cyclic AMP and protein kinase. J Biol Chem. 261:1308213086.[Abstract/Free Full Text]
-
Sial SS, Coggan AR, Hickner RC, Klein S. 1998 Training-induced alterations in fat and carbohydrate metabolism during
exercise in elderly subjects. Am J Physiol. 274:E785E790.
-
Klein S, Young VR, Blackburn GL, Bistrian BR, Wolfe
RR. 1986 Palmitate and glycerol kinetics during brief starvation
in normal weight young adults and elderly subjects. J Clin Invest. 78:928933.
This article has been cited by other articles:

|
 |

|
 |
 
S. B. Roberts and I. Rosenberg
Nutrition and Aging: Changes in the Regulation of Energy Metabolism With Aging
Physiol Rev,
April 1, 2006;
86(2):
651 - 667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. W. Zderic, S. Schenk, C. J. Davidson, L. O. Byerley, and E. F. Coyle
Manipulation of dietary carbohydrate and muscle glycogen affects glucose uptake during exercise when fat oxidation is impaired by {beta}-adrenergic blockade
Am J Physiol Endocrinol Metab,
December 1, 2004;
287(6):
E1195 - E1201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Jin, S.-Z. Li, Z.-S. Zhao, J. J. An, R. Y. Kim, Y. M. Kim, J.-H. Baik, and S.-K. Lim
Carnitine Palmitoyltransferase-1 (CPT-1) Activity Stimulation by Cerulenin via Sympathetic Nervous System Activation Overrides Cerulenin's Peripheral Effect
Endocrinology,
July 1, 2004;
145(7):
3197 - 3204.
[Abstract]
[Full Text]
[PDF]
|
 |
|